Sales of analgesics slow down in 2021, following the boom seen in 2020 due to concerns about COVID-19. Consumers were driven to stockpiling in the first quarter of 2020, through fears they may be unable to obtain medicines if they should need them. This fear was driven by lockdowns and quarantines, concerns about catching the virus, and worries over limited availability of stocks as consumers could see other people stockpiling. Medicine, in particular, is a product area that tends to benefit fro...

Euromonitor International’s Analgesics in Uzbekistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.